COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 14, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy, rehabilitation, and athletic training products, today announced that its management team will present at Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019 in New York City.
Chief Executive Officer Dr. Christopher von Jako is scheduled to present on March 20th at 1:35 PM Eastern Time. He will also conduct one-on-one meetings with investors throughout the day. Investors attending the conference who would like to schedule a one-on-one meeting with Dynatronics management may do so by contacting their Oppenheimer representative, or Jim Ogilvie at jim.ogilvie@dynatronics.com.
About Dynatronics Corporation
Dynatronics is a medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company is headquartered in greater Salt Lake City, Utah, and its products are marketed under a portfolio of brands including Bird & Cronin®, Dynatron Solaris®, Hausmann, Physician’s Choice®, and PROTEAM™. More information is available at www.dynatronics.com.
Contact:
Dynatronics Corporation
Investor Relations
Jim Ogilvie
(801) 727-1755
jim.ogilvie@dynatronics.com
For additional information, please visit: www.dynatronics.com
Like Dynatronics on Facebook
Connect with Dynatronics on LinkedIn
Follow us on Twitter
SOURCE: Dynatronics Corporation
View source version on accesswire.com:
https://www.accesswire.com/539021/Dynatronics-to-Participate-in-Oppenheimers-29th-Annual-Healthcare-Conference-in-New-York-NY
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…